Join ASM and IDSA for the Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)—a premier gathering of scientists, clinicians, industry leaders, and policymakers dedicated to advancing solutions to antimicrobial resistance. Building on the momentum of its successful inaugural meeting, IMARI highlights cutting-edge research, emerging technologies, and innovative strategies in antimicrobial discovery, development, implementation, and stewardship, creating unparalleled opportunities for collaboration across disciplines.
Program highlights include:
- Plenary sessions featuring world-renowned thought leaders
- Scientific symposia exploring advanced topics in antimicrobial resistance
- Industry programs highlighting innovative and emerging technologies
- Poster sessions presenting high-impact research from across disciplines
| Wednesday, January 27 | Thursday, January 28 | Friday, January 29 |
Wednesday, January 27
| 8–9 a.m. |
Industry Breakfast Symposium |
| 9–9:30 a.m. |
Break |
| Concurrent Sessions 9:30–10:30 a.m. |
Concurrent Session 1: A Case of Recalcitrant Mycobacterium Abscessus in the Lung (Sponsored by AAC/JID)
Concurrent Session 2: Structural Basis of β-lactamase Inhibitor Discovery Concurrent Session 3: Combination Therapy Against Fungal Pathogens: PK/PD Considerations |
| 10:30–11 a.m. |
Break |
| 11–12:15 p.m. |
Plenary: New Antimicrobial Agents |
| 12:15–2:15 p.m. |
Lunch and Poster Session |
| 2:15–3:30 p.m. |
Plenary: Are Phages Ready for Prime Time? |
| 3:30-4 p.m. |
Break |
| 4–5:30 p.m. |
Opening Plenary: AMR Solutions and Their Global Impact |
| 5:30-7 p.m. |
Opening Reception |
Thursday, January 28
| 7:45–8:45 a.m. |
Industry Breakfast Symposium |
| 8:45–9 a.m. |
Break |
| Concurrent Sessions 9–10 a.m. |
Concurrent Session 1: A Case of Difficult to Treat Pseudomonas aeruginosa Infection (Sponsored by AAC/JID)
Concurrent Session 2: Breakpoints for BLIs: A Tough Nut to Crack Concurrent Session 3: ARLG Session – Transformational Findings and a Look to the Future |
| 10–10:30 a.m. |
Break |
| 10:30–12 p.m. |
Plenary: Outer Membrane as an Antimicrobial Target |
| 12–2 p.m. |
Lunch and Poster Session |
| Concurrent Sessions 2–3:30 p.m. |
Concurrent Session 1: Artificial Intelligence and Antibiotic Discovery
Concurrent Session 2: Alternative Targets in Antibiotic Discovery Concurrent Session 3: Non-Traditional Approaches for AMR |
| 3:30-4 p.m. |
Break |
| 4-5:15 p.m. |
Plenary: Dissecting End Points for New Antibiotics |
Friday, January 29
| Concurrent Sessions 7:30–8:30 a.m. |
Concurrent Session 1: T32 Trainee Session
Concurrent Session 2: CARB-X Session Concurrent Session 3: Novel Mechanistic Insights into Resistance in Non-Tuberculous Mycobacteria |
| 8:30–9 a.m. |
Break |
| Concurrent Sessions 9–10:30 a.m. |
Concurrent Session 1: Emerging Resistance Mechanisms in Gram-Negative Bacteria
Concurrent Session 2: Emerging Resistance Mechanisms in Gram-Positive Bacteria Concurrent Session 3: Emergent Resistance Mechanisms in Fungi |
| 10:30–11 a.m. |
Break |
| 11 a.m.–12:15 p.m. |
Closing Plenary: Discovering Antibiotics in the 21st Century |